NetworkNewsBreaks

TuesdaySep 05, 2023 11:52 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at Upcoming H.C. Wainwright Global Investment Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be presenting at the 25th annual H.C. Wainwright Global Investment Conference. The conference is slated for Sept. 11–13, 2023, in New York City. According to the announcement, CNS Pharmaceuticals CEO Climaco is scheduled to present during the two-day conference; his live webcast presentation is scheduled for Wednesday, Sept. 13, at 10:30 a.m. ET. In addition to the presentation, key CNPS officials will be available to participate in in-person and virtual one-on-one meetings with…

Continue Reading

TuesdaySep 05, 2023 11:19 am

NetworkNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) CEO to Present at Upcoming H.C. Wainwright Conference

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced that it will present virtually at the H.C. Wainwright 25th Annual Global Investment Conference taking place on Monday, Sept. 11, 2023. The announcement reads, “Knightscope’s Chairman and CEO, William Santana Li, will deliver a corporate overview followed by question-and-answer sessions with analysts and attendees. The event begins at 7:00 a.m. ET and will be available on demand by registering here.” To view the full press release, visit https://nnw.fm/eWm1s About Knightscope, Inc. Knightscope is an advanced public safety technology company that builds fully…

Continue Reading

TuesdaySep 05, 2023 10:12 am

NetworkNewsBreaks – Upstream Blog Points Out Benefits of Adding NFTs to More Traditional Customer/Fan Rewards Programs

Upstream, the revolutionary retail trading app for stocks and NFTs powered by Horizon Fintex and MERJ Exchange Limited, recently discussed how digital collectibles can drive engagement and foot traffic, while also leading to increased sales. The Upstream blog pointed out that in a rapidly evolving digital landscape, the process of rewarding customer loyalty has the potential to undergo a remarkable evolution, thanks to the emergence of non-fungible tokens (“NFTs”), which allow brands to redefine the way they engage with their audience. The blog outlined several key benefits of adding digital collectibles to fan or customer engagement strategies. Those benefits include…

Continue Reading

FridaySep 01, 2023 3:45 pm

NetworkNewsBreaks – Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) (FWB: HF2) Looking to Improve North America’s Graphite Infrastructure Efficiencies to Meet Surging Demand

Reflex (CSE: RFLX) (OTCQB: RFLXF) (FWB: HF2) is advancing its flagship Ruby Graphite Project in Beaverhead County in southwestern Montana. “With its ‘mine-to-market’ strategy, Reflex aims to improve domestic specialty mineral infrastructure efficiencies to meet surging national demand from North American manufacturers, effectively positioning itself as one of the only North American suppliers of high purity natural graphite for hi-tech applications… Preliminary results from the TDEM and magnetic survey have demonstrated promising anomalies, indicating the presence of conductive structures, several new anomalies, and potential graphite mineral deposits within the Ruby Graphite property. The survey data will be integrated with existing…

Continue Reading

FridaySep 01, 2023 2:39 pm

NetworkNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Positioned Favorably with Worldwide License to Anti-IL-17 NanoAbs

BiondVax (NASDAQ: BVXV), a biotechnology company that recently signed an exclusive worldwide license to develop and commercialize innovative alpaca-derived nanosized antibodies (“NanoAbs”) targeting IL-17 cytokines as treatments for psoriasis and psoriatic arthritis, recently received coverage in analysis by Aegis Capital Corp. The report, which reiterated a buy recommendation and $70 target price for BVXV, contained analysis highlighting a deal valued at approximately $2.4 billion for Eli Lilly and Company’s (NYSE: LLY) acquisition of DICE Therapeutics Inc. (NASDAQ: DICE), a biopharmaceutical company that develops oral therapeutic candidates – such as DC-806 and DC-853, both oral interleukin-17 (“IL-17”) inhibitors – currently in…

Continue Reading

FridaySep 01, 2023 1:02 pm

NetworkNewsBreaks – Why Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Is ‘One to Watch’

Prospera (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B), a public oil and gas exploration, exploitation, and development company focusing on conventional oil and gas reservoirs in Western Canada, uses its experience to develop, acquire and drill assets with potential for primary and secondary recovery. “Prospera’s core properties include more than 42,000 cumulative acres across Cuthbert, Luseland and Heart Hills in Saskatchewan and Red Earth and Pouce Coupe in Alberta. In total, the company estimates that there are half a billion barrels of oil in place at these sites accounting for 20+ years of forward project lifespan, with as little as 8%…

Continue Reading

FridaySep 01, 2023 1:00 pm

NetworkNewsBreaks – GolfLync Inc.’s Pebble Beach Sweepstakes Provides Once-in-a-Lifetime Opportunity for Golf Enthusiasts

GolfLync, the company behind the GolfLync app – a social network for matching golf games and players, previously announced the launch of the GolfLync Pebble Beach Sweepstakes. “This exciting sweepstakes gives golf enthusiasts a chance to win a dream golf trip to the iconic Pebble Beach Resorts, renowned as the No. 1 Golf Resort in America… As the greatest public golf course in America, as rated by Golf Digest, Pebble Beach has a rich history of hosting prestigious tournaments, including the U.S. Open and, for the first time in 2023, the U.S. Women’s Open. This sweepstakes provides a once-in-a-lifetime opportunity…

Continue Reading

FridaySep 01, 2023 12:26 pm

NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Secures Patent Protection in ‘Some of the Most Important Markets in the World’

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, recently received a patent from the China National Intellectual Property Administration. “The granted patent broadly covers the use of the company’s drug candidate REQORSA(R) immunogene therapy in combination with PD-1 antibodies, such as Keytruda(R), to treat cancers. The REQORSA gene therapy in combination with Keytruda is the subject of the company’s ongoing Acclaim-2 clinical trial for the treatment of non-small cell lung cancer (‘NSCLC’). In this trial, the company is enrolling and treating patients with advanced, metastatic NSCLC whose disease progressed…

Continue Reading

FridaySep 01, 2023 12:00 pm

NetworkNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K5 and K1 ASRs to Patrol New York-Based Pharmaceutical Facility

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced a new 7-robot contract with a publicly traded biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. The new client subscribed to one K5 ASR assigned to patrol a 4-story garage and six K1-Tower ASRs to monitor building entrances, open areas and parking lots throughout the corporate campus. The announcement reads, “A secure and resilient pharmaceutical supply chain in the United States is the best means to ensure that U.S. patients and the health care system…

Continue Reading

FridaySep 01, 2023 11:31 am

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) CEO Responds to Question Asked on ‘Making Money with Charles Payne’

Mullen Automotive’s (NASDAQ: MULN) CEO and Chairman David Michery appeared on “Making Money with Charles Payne” on Fox Business on Thursday, Aug. 31, to discuss the lawsuit against large brokerage firms for unlawful trading practices of the company’s stock and other matters. The company today announced its response to a question asked during Michery’s appearance on the program, which aired on Fox Business at 2:55 p.m. ET on Aug. 31, 2023. Michery and Wes Christian of the law firm of Christian Attar were interviewed by host Charles Payne to discuss various matters and, notably, Mullen’s recent lawsuit against large brokerage…

Continue Reading